Skip to main content

Fourteen years of manifestations and factors of health insurance fraud, 2006–2020: a scoping review



Healthcare fraud entails great financial and human losses; however, there is no consensus regarding its definition, nor is there an inventory of its manifestations and factors. The objective is to identify the definition, manifestations and factors that influence health insurance fraud (HIF).


A scoping review on health insurance fraud published between 2006 and 2020 was conducted in ACM, EconPapers, PubMed, ScienceDirect, Scopus, Springer and WoS.


Sixty-seven studies were included, from which we identified 6 definitions, 22 manifestations (13 by the medical provider, 7 by the beneficiary and, 2 by the insurance company) and 47 factors (6 macroenvironmental, 15 mesoenvironmental, 20 microenvironmental, and 6 combined) associated with health insurance fraud. We recognized the elements of fraud and its dependence on the legal framework and health coverage. From this analysis, we propose the following definition: “Health insurance fraud is an act of deception or intentional misrepresentation to obtain illegal benefits concerning the coverage provided by a health insurance company”. Among the most relevant manifestations perpetuated by the provider are phantom billing, falsification of documents, and overutilization of services; the subscribers are identity fraud, misrepresentation of coverage and alteration of documents; and those perpetrated by the insurance company are false declarations of benefits and falsification of reimbursements. Of the 47 factors, 25 showed an experimental influence, including three in the macroenvironment: culture, regulations, and geography; five in the mesoenvironment: characteristics of provider, management policy, reputation, professional role and auditing; 12 in the microenvironment: sex, race, condition of insurance, language, treatments, chronic disease, future risk of disease, medications, morale, inequity, coinsurance, and the decisions of the claims-adjusters; and five combined factors: the relationships between beneficiary-provider, provider-insurance company, beneficiary-insurance company, managers and guānxi.


The multifactorial nature of HIF and the characteristics of its manifestations depend on its definition; Identifying the influence of the factors will support subsequent attempts to combat HIF.


Corruption and fraud are embedded in health systems (HS), and they are motivated by abuse of power and dishonesty (García, 2019) that harm the user population, generating economic and even human losses (World Bank, 2018). The different aspects of corruption seriously weaken the access and performance of the HS; among the most affected, equity, quality, response capacity, efficiency and resilience should be mentioned (W. H. Organization, 2016). In the world, more than seven billion dollars are spent on health services from those,  between 10% and 25% of spending is directly lost as a result of corruption, an amount that exceeds the annual estimate for 2030 in providing universal health coverage (Jones & Jing, 2011; World Bank, 2019). In addition, there is a constant increase in healthcare spending, healthcare professionals seeking to maximize their profits, and health insurance seeking to contain costs (Dumitru et al., 2011; Wan & Shasky, 2012).

Fraud in the HS is often included in the discussion of corruption since these practices generally involve abuse of power (Vian, 2020). Health insurance fraud (HIF) is a substantive component of the HS crisis (Manchikanti & Hirsch, 2009). The HIF mainly affects developing countries with fewer resources (Perez & Wing, 2019), weakened health systems and a lack of quality, causing significant losts and inefficiencies (Kruk et al., 2018). Losses caused by HIF in some high-income countries range between 3 and 10% (Rashidian et al., 2012), and its main motivation is the search for money by fraudsters, to which other individuals, organizational or contextual factors are added (Busch, 2012; Wan & Shasky, 2012). HIF is a problem that ranks second after violent crimes in the United States (USA) (Sparrow, 2008) and can be committed by medical providers, policyholders and health insurers (Busch, 2008). In this sense, it is essential to identify and understand the factors that influence HIF and its manifestations to combat them and reduce losses in HS.

The public health programmes of the different countries of the world propose interventions to prevent and detect HIF, many of which lack effectiveness in their results. Although the interventions include multiple deterrence efforts and strategies based on data mining, they are insufficient to show effective results to combat HIF (Abdallah et al., 2016; Bayerstadler et al., 2016; Hassan & Abraham, 2013; Joudaki et al., 2015; Kang et al., 2010; Kelley et al., 2015; Kose et al., 2015; Li et al., 2008; Lin et al., 2013; Ormerod et al., 2012; Perez & Wing, 2019; Rashidian et al., 2012; Shi et al., 2016). Likewise, scientific evidence indicates a shortage  of studies that address how to deal with fraud effectively in the health sector; however, it identifies some promising interventions, such as the actions of an independent agency, prohibitions, internal control practices, transparency, accountability, among others, but it is unknown whether or not they contribute to reducing corruption (Gaitonde et al., 2016). In this same sense, the evidence shows that despite the efforts made to reduce HIF, it is a complex problem difficult to address.

HIF, as a fraud, is multifaceted, multidimensional and interrelated, mainly caused by the insufficiency of theories that can explain its complexity (Huber, 2017). Part of the complexity of the HIF is supported by the dynamic behaviour of fraudsters, which generates the need for human interaction to identify suspected cases (Travaille et al., 2011), given the scarce specialization in detection interventions, which are limited to opportunistic verifications of previously known patterns and detections by coincidence (Bayerstadler et al., 2016). On the other hand, complexity is supported by the lack of a standardized definition of the HIF, which does not have a consensual definition; however, it could refer to deception or intentional misrepresentation used to obtain illegal benefits, making it difficult to distinguish from abuse, waste or error (Hyman, 2001; Joudaki et al., 2015; Lee et al., 2020; Rashidian et al., 2012) In addition, its manifestation will depend on regulation and market behaviour (Bayerstadler et al., 2016; Green, 2007). The proposal of a definition seeks to contribute to the development of better strategies (Kacem et al., 2019).

Given the absence of a standardized definition of HIF, this scoping review could contribute to filling a gap in knowledge, providing a definition with a homogeneous language, which can dispel ambiguity and facilitate its understanding. In this sense, the objective of our scope review is to define the HIF, identify the causes or factors that influence, and the consequences or manifestations that occur; for which we will answer the following questions: What is health insurance fraud? How is health insurance fraud manifested? Furthermore, what factors influence health insurance fraud?

The results obtained are intended to promote future studies that more effectively channel the interventions that prevent, detect, and provide responses to combat HIF and be a reference for decision-making in countries’ public health.


To answer our research questions, we conducted a scoping review, using a rigorous literature review method, which establishes conceptual limits, following the considerations of the document “PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation” (Tricco et al., 2018). In Additional file 1, we include the Checklist for Scoping Reviews (PRISMA-ScR).

Scoping reviews allow answering broad questions such as those posed by our study, while systematic reviews allow answering clearly defined questions (Tricco et al., 2018). The scoping review aims to identify gaps in knowledge, analyze the literature body, clarify concepts, or investigate the nature of a problem (Munn et al., 2018). In this sense, our research questions seek to examine and clarify the definition used in the literature on HIF and show how this theoretical definition becomes tangible and shown in reality through the manifestation. As fraud is a complex problem, we also seek to identify and inventory the associated factors that influence it. Our contribution provides new elements of judgment to confront the HIF, it will facilitate the redesign and innovation of practical strategies that help combat fraud, and we hope that other studies will join the few that have demonstrated effectiveness in their interventions.

Eligibility criteria

We reviewed studies according to our objective, and we included those reviewed by peers and are indexed to international databases since they are considered validated knowledge. We limited our search from January 1, 2006, to July 31, 2020, taking into account that the U.S. Department of Health and Human Services issued in 2006, the final rule that establishes civil monetary sanctions, procedures for investigations and hearings, for violating the Health Information Portability and Privacy Act (Tovino, n.d.). In addition, we observed that starting in 2006, monetary recoveries from HIF sanctions increased by 40% compared to the previous 20 years (Helmer Jr, 2012). The search had no geographic or language restrictions. However, we exclude conferences, proceedings, posters, editorials, letters, misprints and books, as they do not provide reliable scientific evidence. We also excluded studies with meanings ascribed to health abuse related to drugs, diseases, suicide, racism, food fraud, security, network, web, and  electronics device; all of them for being away from the health insurance environment.

Information sources

To identify the documents, we conducted a scoping review search in ACM, EconPapers, PubMed, Science Direct, Scopus, Springer and Web of Science between January 1, 2006, and July 31, 2020.

Search strategies

To guarantee not to lose potential studies, we applied an iterative approach; we initially used the studies that met the inclusion criteria in PubMed and WoS. The search strategy included a combination of keywords and medical topic headings (MeSH for PubMed), terms related to “Fraud healthcare” (concept A) and “Health Insurance” (concept B). Subsequently, we used the results of this search to identify keywords and MeSH terms, which were adapted in the search strategies of the other databases, as reported in Additional file 2. A health librarian reviewed the search strategy.

Data process, evaluation and quality of the study

Once we applied the search strategies and identified the potential studies, two authors made the review separately as follows: we designed a matrix in Excel, in which we listed all the studies characterized by name, code, among others (Additional file 3). In order to perform the first screening in the database, we ordered the studies by titles and authors, and eliminated duplicates, both authors in consensus. In a second selection, we reviewed the titles, abstracts and conclusions of the selected studies; for this, each author considered the eligibility criteria of the study, in the end, both authors agreed on the list. Once the possible studies had been chosen, the two authors read the full text, which allowed us to select those that contribute directly to the research questions (Theoretical Fraud, Practical Manifestation, Factors), and we identified them in the matrix; finally, the authors reached at a consensus. Subsequently, we evaluated the content and explicit references to answer the research questions; We have avoided conjectures or interpretations. In addition, we considered the theoretical or experimental contribution of each study for the factor inventory and showed the influence (if the factor increases or worsens the HIF, we used the positive sign, while if the factor reduces the HIS, we registered the negative sign; a result could also indicate an ambivalent influence so we used both signs). We have considered a consensus greater than 95%, and the differences were discussed and cleared for both autor based on screening, eligibility, and final inclusion of the studies. However, we excluded studies that did not contribute to any questions.

We reviewed 67 pairs of articles included in the study, both qualitative and quantitative, and with the help of the matrix, we discussed the results and reached a consensus on the information extraction. To evaluate the quality and rigour of the studies, we used a tool for integrative reviews, which is based on four factors: type of study, sampling method, detail of the data collection method, and analysis. The possible score generated by this tool varies between 4 (qualitative design, sampling and collection of unexplained data, and narrative analysis) and 13 (quantitative experimental design, random sampling, explained data collection and inferential statistics) (Olsen & Baisch, 2014; Pfaff et al., 2014). The details of the quality scores of the included studies can be seen in Additional file 4. To ensure the strength of the evidence and the studies’ quality, the authors independently graded the articles in rounds, and disagreements were resolved through discussion until an agreement more significant than 95% was achieved. In addition, we evaluated the SCImago journal rank (SJR), which measures the scientific influence of academic journals according to the number of citations of the journal to which each of the included manuscripts belonged, which is justified by the high quality of publications over the years (Ardito et al., 2015).


Selection of studies

A total of 944 studies were identified following the selection criteria. Subsequently, 84 duplicate studies were eliminated, and then the titles, abstracts and conclusions of 860 studies were examined, from which 89 full texts were recovered, to which we incorporated two relevant studies identified from other sources (a thesis referred by the authors selected from 2003 and another reference document on fraud issues of the National Health Care Anti-Fraud Association of 2018). In the process, we excluded 24 studies related to HIF detection techniques, data mining models, processes, activities or other aspects not related to the factors and manifestations of HIF. Finally, we included 67 studies (Fig. 1).

Fig. 1
figure 1

PRISMA flow diagram

RQ1: definition of health insurance fraud

We identified six definitions of HIF and the key elements of each of them to integrate them into a single consensual definition, as shown in Table 1. General definitions of fraud that included intensity of desire, risk of apprehension, violation of trust, rationalization (Ramamoorti & Olsen, 2007), also defined as the obtaining of a financial advantage, or the cause of a loss through an implicit or explicit deception using a mechanism through which the fraudster obtains an illegal advantage or causes an unlawful loss (Levi & Burrows, 2008).

Table 1 Definitions of health insurance fraud

Based on what is described in Table 1, we have identified and classified five key elements that incorporate the six definitions shown, and subsequently, we have integrated them, as shown below:

  1. A.

    It is deceptive, and the people involved tend to deceive, lie, hide and manipulate the truth. Five definitions affect the term “deception”, which is associated with an act linked to misrepresentation and deception.

  2. B.

    It is intentional; Fraud is not the result of simple error or negligence but involves deliberate attempts to obtain an illegal advantage; thus, it induces a course of action predetermined by the perpetrator (Pickett & Pickett, 2002) 47. Five definitions affect the term “intentional”, which is associated with a deliberate act.

  3. C.

    Obtains a benefit, profit or advantage; Usually, the benefit is economic, which implies that there is a victim and that the action produces losses of individual, organizational, and even national resources.

  4. D.

    It is illegal, and some definitions describe it as a criminal act or severe federal crime. To establish an illegal act, you must break the law. Some practices may be legal in some countries, but not necessarily in others; it will depend on the rules and regulations of each country or state.

  5. E.

    Health insurance coverage (HIC), taken from the definition of health insurance, allows us to circumscribe the scope. The synonyms of HIC used are “health coverage”, “medical care coverage”, and “health benefits” (Elwyn et al., 2000) 48.

To have a single definition of HIF, we have again integrated what is described in A, B, C and D, from which we obtained that “Fraud is a deliberate deception to obtain unfair or illegal profits”, a statement that is complemented by described in E. We specified that the absence of one of five key elements identified puts at risk the comprehensive definition of HIF. Finally, we arrived at the following definition:

“Health insurance fraud is an act based on deceit or intentional misrepresentation to obtain illegal benefits concerning the coverage provided by health insurance.”

To illustrate the elements that comprise the definition of HIF, we showed Fig. 2, in which we show the relationship they have with its factors (RQ2) and manifestations (RQ3).

Fig. 2
figure 2

Elements of the definition of health insurance fraud, its factors and manifestations

RQ2: manifestations of health insurance fraud

We found that fraud manifests itself in multiple ways, such as performing unnecessary services, falsifying records, separating invoices, and misrepresented coding. Therefore, we classified the manifestations by actor (Li et al., 2008; Sheffali & Deepa, 2019). In this sense, we present the manifestations by a) health service providers, including hospitals, laboratories, and health care professionals; b) insurance underwriters, including patients; and c) public or private health insurance companies, which include state-subsidized programmes.

In 23 studies, we identified 13 manifestations of fraud by the provider; the three most common manifestations are phantom billing based on claims presented for medical services not provided, mentioned in 14 studies, the falsification of administrative or clinical documents in 10 studies and the proportion of unnecessary care in 9 studies. In 16 studies, we identified seven manifestations of fraud by the subscriber; the three most frequent are identity fraud mentioned in 8 studies, manipulating the eligibility information and manipulation of documents, both noted in 4 studies. Finally, in two of the studies, two manifestations of fraud of the agent or insurer were identified: false declarations of benefits or services and falsification of reimbursements. Each manifestation was briefly described, and one or more examples were provided. We observe that each study could contribute to more than one manifestation. For a better understanding, we showed Table 2.

Table 2 Manifestation of health insurance fraud by the provider

RQ3: health insurance fraud factors

In this study, we define the factors as elements that can originate or influence the HIF. They can be categorized in multiple ways, such as by actors: internal staff, patient, intermediary and insurer (Yusuf, 2010); and by environment: context, organization and individual (Vahdati & Yasini, 2015; Vian, 2020), or internal and external (Akomea-Frimpong et al., 2016). These categorizations do not consider the relationship between each category, although factors influence more than one category, as in the doctor-patient interaction. Therefore, we added a new category called the collaborative environment, which includes interaction factors between different categories, either classified by actor type, or environment. For the presentation of the factors related to the HIF, we considered the macroenvironment categories if the factors are motivated by external influences (Lesch & Baker, 2013); mesoenvironment, if the factors are inspired by the context of the organizations; microenvironment, if the factors are associated with demographic and individual characteristics; and the collaborative environment.

We identified 47 factors that influence the occurrence of health insurance fraud, categorized into macroenvironment (6), mesoenvironment (15), microenvironment (20) and collaborative (6). For each study, we denoted with a positive sign (+) when the factor increased the HIF, and a negative sign (−) if the factor reduced the HIF; when used a single sign, it indicated that the study proved a theoretical or narrative contribution. A factor can show both signs simultaneously (+−), which means that its influence is ambivalent. In contrast, a double sign indicated that the study had an applied validation based on a method de experimentation or quasi experimentation.

Macroenvironment factors

A total of 14 studies explain 6 factors, 8 studies refer to norms and regulations, 3 studies to economic, political and social issues, and 3 studies to cultural issues. We can observed that some applied studies involve more than one factor. Culture is the only factor that contributes to increasing HIF (Zourrig et al., 2018); rules and regulations (Lesch & Baker, 2013) and geography (Manocchia et al., 2012) show an ambivalent influence, conditioned on the environment in which they were studied. At the theoretical level, it is found that complexity, infrastructure and economic, political and social conditions influence the HIF.

Mesoenvironment factors

We identified 26 studies that explained 15 factors, the most referenced factors are audit, supervision and control, with 8 studies, while 6 studies explain the general characteristics of the provider. The factors supported by applied studies that have shown influences in favour of the HIF occurring are the general characteristics of the provider (Herland et al., 2018; Kang et al., 2010), in favour of the HIF decrease (Vian, 2020), ambivalent (Massi et al., 2020); the management and policy of complaints show results that contribute to HIF (Vian, 2020) and ambivalent results (Lesch & Baker, 2013); while that the reputation shows ambivalent influence (Tseng & Kang, 2015), the audits, supervision and control contributes to reducing the HIF (Kang et al., 2010).

Each Macroenvironmental and Mesoenvironmental factor was briefly described, and one explanation was provided. We can observed that some studies involved more than one factor. For a better understanding, we present Table 3. In the next session, we analyze the studies according to the quality methodology proposed in this work to specify our findings in greater detail.

Table 3 Macroenvironmental and Mesoenvironmental factors that influence health insurance fraud

Microenvironment factors

A total of 35 studies contributed to explaining 20 factors of the microenvironment (see Table 4). Applied studies show that the two most referenced factors are prescription medications, and ethics and morals, both with 11 studies each. Other relevant factors are those related to demographic characteristics, among which sex and age stand out, with 4 studies each. In a study conducted in the state of Florida, USA, we found statistically significant results that encourage HIF: the western region, being a woman, being white, having health insurance, predominantly English language, having a condition sensitive to health, greater future risk of illness, health condition (Manocchia et al., 2012). Another factor that positively influences HIF is the prescription, dispensing, cost and consumption of medications (Aral et al., 2012; Herland et al., 2018; Lin et al., 2008; Liou et al., 2008; Weiss et al., 2015). In addition, factors related to users’ perceptions of health services such as inequity, injustice (Lesch & Baker, 2013), high deductibles, and coinsurance (Lammers & Schiller, 2010) can condition the HIF. Regarding the attitudes of claims adjusters, their decision is fickle, and has been demonstrated experimentally ambiguous (Tseng & Kang, 2015). Finally, the values that regulate human behaviour, such as ethics and morals, determine fraud.

Table 4 Microenvironmental and Collaborative factors that influence health insurance fraud

Collaborative factors

A total of 10 studies contributed to explaining 6 collaborative factors (see Table 4), in which the most referenced factor was the relationship between the provider and the patient, with 3 studies. Relationships between the consumer provider, provider insurer (Lin et al., 2008), consumer insurer (Manocchia et al., 2012), the influence of bosses (Tseng & Kang, 2015) and gGuānxi (Tseng, 2016) encourage the increase in HIF.

We have proceeded to an analysis of the 47 identified factors, their corresponding influences supported by theoretical or applied contributions to increasing or decreasing the HIF (Tables 3 and 4). We also considered evaluating the quality of the 53 studies (Additional file 4) that support our RQ3 question (Fig. 1). For a better presentation, we categorized the studies by their quality score: high (11 to 13), medium (7 to 10) and low (4 to 6); the results are presented in Table 5.

Table 5 Studies that identify factors according to their quality assessment

We confirmed that the factors are affected by other factors and depend on their studied and developed context. In the macroenvironment, in the category of high quality, concerning the factors, no study showed the influence on the HIF, while the geography presented theoretical influence in favour of the HIF, supported by a theoretical study. On the other hand, if we analyzed the category of medium quality, culture contributes to an increase in the fraud supported by an applied study (Zourrig et al., 2018), even when a theoretical study shows that it decreases the HIF.

In the mesoenvironment, in the high-quality category, the factors related to the audit, supervision, sanction, control (Hillerman et al., 2017; Maroun & Solomon, 2014; Myckowiak, 2009; Smith et al., 2013; Vian et al., 2012), and the type of health professional, particularly the nurses (Goel, 2020), shows influence in reducing HIF. Additionally, the general characteristics of the provider contribute to an increase in the HIF supported by two applied studies (Herland et al., 2018; Kang et al., 2010); even though a theoretical study shows that the HIF decreases, this study also confirms that the lack of policies and management of complaints increases fraud (Wan & Shasky, 2012). In this category, other factors (medical record, provider responsibility, provider internal mechanisms, internal staff evaluations, patient identification mechanisms, among others) have been shown to contribute to reducing HIF; several are theoretical or of medium or low quality.

In the microenvironment, in the high-quality category, no applied studies have demonstrated an influence that reduces HIF. While the factors related to having an older age to be deceived (> 65), place of residence (Goel, 2020), patient diagnoses, medical and surgical treatments (Liou et al., 2008), medications (Aral et al., 2012; Herland et al., 2018; Lin et al., 2008; Liou et al., 2008; Weiss et al., 2015), chronic health condition (Liou et al., 2008), and deductibles and coinsurance (Lammers & Schiller, 2010) showed influence in increasing the HIF. However, other theoretical studies showed that the diagnoses (Sun et al., 2020) and medications reduced HIF (Haddad Soleymani et al., 2018; Sun et al., 2020; Victorri-Vigneau et al., 2009). It is important to mention the factor related to ethics and morals, which has shown a theoretical and applied contribution to reducing the HIF.

In the high-quality category of collaborative environment, the provider-insurer relationship (Lin et al., 2008), the consumer-provider relationship (Lin et al., 2008), and bosses influence (Tseng & Kang, 2015); increased HIF. Also, in the middle-quality category, the consumer-insurer relationship (Manocchia et al., 2012), the Guānxi (Tseng, 2016), showed influence in increasing the HIF.


We analyzed 67 primary studies from January 2006 to July 2020, including definitions, manifestations, and HIF factors. Our findings identified 6 theoretical definitions, 22 manifestations (13 of the provider, 7 of the insurer and 2 of the insurer) and 47 factors categorized into macroenvironment (6), mesoenvironment (15), microenvironment (20), and collaborative (6).

Definition fraud

The HIF definition that we have found is related to the general definition of insurance fraud given by the International Association of Insurance Supervisors (IAIS), which defines fraud as an act intended to obtain a dishonest advantage (IAIS, 2011). Similarly, the nongovernmental organization Transparency International defines fraud as a criminal or civil crime that consists of intentionally deceiving someone to obtain an unfair or illegal advantage (financial, political or otherwise) (Transparency International, 2017). In this same sense, other authors determine fraud as a criminal deception to generate illegal financial gains (Steinmeier, 2016). Likewise, Onwubiko specifies the concept of fraud as a criminal offence, illegal, intentional, deliberate act, characterized by deception, concealment, violation of trust or the use of dishonest means, which can cause injury or material damage (Onwubiko, 2020). In addition, our definition of HIF includes the one given by Yusuf et al.: «... is the one that covers the payments of benefits as a result of an illness or injury, includes insurance for accidental losses, medical expenses, disability or accidental death and dismemberment» (Yusuf & Ajemunigbohun, 2015). The HIS also identifies an institution or programme that helps pay for medical expenses, either through privately acquired health insurance, social insurance or a social welfare programme funded by the government (Brooks et al., 2017).

With the HIF definition, we seek to dispel the omission of a standard definition and highlight their element variability, which will potentially contribute to better identifying the characteristics of fraud, its causes (factors), manifestations, consequences and delimiting the differences with abuse, and the error. In general, the term abuse is used to define the practices of providers that result in unnecessary costs; these activities do not constitute fraud because they are legal (Gasquoine & Jordan, 2009). Likewise, the error is not intentional, so it does not constitute fraud (Brooks et al., 2017). These differences make the identification of the HIF more complex.

However, legal frameworks refer to fraud as a “conceptual swamp” (Green, 2007). The definition of HIF depends on the legal framework and regulations of the country or each state, so the same practices could be legal or illegal depending on their regulations. In the USA, the HIF is highly regulated with laws such as the Federal False Claims Act statute (31 USC 3279) - FCA and the Anti-Kickback Statute (42 USC 1320 a - 7) AKS., the Physician Self-referral Law (42 USC 1395nn)-StarK, the Health Insurance Portability and Accountability ACT of 1996-HIPAA (Myckowiak, 2009), while in other countries they lack regulation; so it could not be constituted in HIF.

The HIF definition is made tangible through its manifestations, which have been grouped into three categories: provider, underwriter, and insurer. In any category, the demonstration must meet the HIF definition and show intentionality on the perpetrator’s part to obtain some benefit. The act of defrauding is conscious and is evidenced day by day by self-referring patients, providing unnecessary care or misrepresenting clinical and administrative documents. However, when the evidence, they often argue deficiencies in supplies, medical materials, stock, in the number of professionals or sustain that the equipment is damaged or under maintenance, thereby circumventing the true intentions that they have as perpetrators.

Manifestation of fraud

The most frequently studied manifestations are related to the provider, like ghost claims, the manipulation of documents and unnecessary care, where deception and intentional misrepresentation are the most evident. While in other manifestations such as coding, billing for services provided by unskilled personnel, and duplication of billing. They are more complex to detect and separate the error intentionality. At this point, experts must make strenuous efforts to develop cost-effective tools or strategies to separate and recognise the provider’s intent.

On the other hand, we appreciate that some manifestations lack studies, such as self-reference, a widespread manifestation and public knowledge, becoming even a common practice in HS. This phenomenon is explained by having a culture permissive to fraud, where ethics and morals are often bypassed by economic interests, the lack of patients to report and lax legislation. From the HIF manifestations of the subscriber, we found identity fraud more frequently, the one that takes advantage of the absence or inefficiency of the controls, and the one that clearly shows intentionality and deception. However, there is little evidence of the HIF manifestation defined as “Doctor Shopping” since it is confused with abuse, which will depend on regulation. A characteristic of the manifestations of the insurers' HIF is that they do not make the fraud visible since the organisations prefer to separate the fraudster silently protecting the reputational risk.

Factors fraud

Regarding the factors, we have identified that they can increase or decrease the HIF. Moreover, these factors are interrelated in various ways, constituting a complex network whose behaviour over time could, to some extent, be unpredictable, contradictory and ambiguous. According to Brugé et al., «... the main problem lies in contrast between the simplicity of our administrations and the complexity of the problems to be solved; the classical administrative modus operandi consists of simplifying problems by reducing themselves to a specialized field...»; This explains why our results show the same factor with ambivalent influence, which confirms the sensitivity of the factors (Brugué et al., 2015).

The results in Table 5 compared Tables 3 and 4, considering with the quality assessment of the studies 5; in order to verify whether the initially found results maintain an influence on the HIF after considering only high and medium quality studies and excluding ambivalent results; and we find within the macroenvironment factors that norms and regulations confirm an increase in fraud (Ribeiro et al., 2020) as well as geography (Musal, 2010). However, the economy, politics and social conditions confirm a decrease in fraud (Ribeiro et al., 2020). On the other hand, the infrastructure (Brooks et al., 2012), the complexity of the health systems (Vian et al., 2012) (Faux et al., 2019) lose influence in favour of increasing the HIF. All this, supported by theoretical studies. Furthermore, with mixed results, we found that culture maintains the results concerning HIF (Ribeiro et al., 2020; Zourrig et al., 2018).

Likewise, by continuing with the verification of the results of the mesoenvironmental factors, considering only high and medium quality studies, we analyzed that the general characteristics of the provider, supported by applied studies, confirm the ambivalent results (Herland et al., 2018; Kang et al., 2010; Wan & Shasky, 2012). The Payment method and contracts also show ambivalent results and lose their influence on the HIF. The responsibility of the provider (Kerschbamer & Sutter, 2017), the measures of the administrative authority (Jator & Hughley, 2014), and the internal mechanisms of discipline (Myckowiak, 2009), the performance and quality evaluation system (Kerschbamer & Sutter, 2017), the commercial implication (Konijn et al., 2015), the employability and satisfaction with his work (Brooks et al., 2012), patient identification mechanisms (Jator & Hughley, 2014); they lose their influence in favour of reducing fraud, all supported by theoretical studies. Reputation only shows ambivalent results and loses its influence. Additionally, reimbursement processes and billing characteristics (Hillerman et al., 2017) confirm an increase in the HIF. Also, the Lacks of Complaints management and policy confirms the increase to HIF (Wan & Shasky, 2012) even when another theoretical study opposes this statement (Lee et al., 2016). An important finding is the audit, supervision, sanction and control, supported by an applied study (Kang et al., 2010) and two theoretical studies (Hillerman et al., 2017; Smith et al., 2013). The role of nurses, supported by an applied study (Goel, 2020), confirms their contribution to reducing fraud. Finally, the medical record supported by a theoretical study (Smith et al., 2013) confirms a decrease in HIF.

When interpreting the results of the microenvironment factors, we verify that an applied study confirms that being a women, and the risk of becoming ill, increase the probability of fraud (Manocchia et al., 2012); it is worth mentioning that the proportion of women who seek medical attention is higher than men. Likewise, an applied study confirms that the involvement of adults over 65 years of age increases the probability of fraud (Goel, 2020), and other theoretical studies confirm this (Timofeyev & Busalaeva, 2019; Zhou et al., 2016). As well as, being married maintains mixed results (Zhou et al., 2016) concerning HIF. In addition, the predominant white race (Manocchia et al., 2012), and the place of residence in more urbanized areas (Goel, 2020), confirm the increase in HIF based on applied studies; other theoretical studies confirm this finding (Musal, 2010; Ribeiro et al., 2020). Likewise, having health insurance, speaking an official language of the country based on an applied study increases the HIF (Manocchia et al., 2012). Also, the influence of diagnoses confirms an applied result that encourages HIF (Liou et al., 2008).

Two applied studies, and one theoretical study confirm that medical and surgical treatments, and chronic health condition increase the probability of fraud,  (Liou et al., 2008; Manocchia et al., 2012; Hillerman et al., 2017). In addition, the medical specialities and the bad economic situation confirms an increase in fraud, supported by an applied study (Shin et al., 2012). As well as, the influence of drugs confirms applied results that incentivize HIF (Aral et al., 2012; Herland et al., 2018; Lin et al., 2008; Liou et al., 2008; Weiss et al., 2015), Two applied studies confirm that medical and surgical treatments increase the probability of fraud (Liou et al., 2008; Manocchia et al., 2012). Another theoretical study confirms this claim (Hillerman et al., 2017). Additionally, the perception of inequity and injustice supported by a theoretical study (Ribeiro et al., 2020) and the asymmetry of information supported by three applied studies (Kumar et al., 2011; Ribeiro et al., 2020; Zhou et al., 2016) confirm a decrease in fraud. Also, for the decisions of the adjusters, the reputation only shows ambivalent results. Further, the capacity building shows results in favour of reducing HIF and loses influence. Likewise, the high deductibles and coinsurance, supported by an applied study, confirm the increase to the HIF (Lammers & Schiller, 2010).

Regarding the collaborative environment, we have been able to verify that the relationship between the health professional and the patient confirms an increase in HIF (Shin et al., 2012). An applied study confirms a strong relationship between the provider and the insurer and that they increase the probability of fraud (Lin et al., 2008), and a theoretical study confirms this statement (Bayerstadler et al., 2016). An applied study confirms that a strong relationship between the consumer and the provider increases the probability of HIF (Lin et al., 2008). Two other theoretical studies confirm this statement (Musal, 2010; Shin et al., 2012). The consumer-insurer relationship, the influence of the bosses (Tseng & Kang, 2015), and Guānxi (Tseng, 2016) are support by applied studies, confirms the increase in HIF.


Regarding the limitations of our study, some deserve special attention. Regarding the design, we can mention the selection biases that did not include conferences, posters, editorials, letters, misprints and grey literature; however, we included the most relevant evidence from indexed journals. Likewise, another bias can be attributed to the limited search, that the range from January 1, 2006, to July 31, 2020, which it is justified by fraud penalty rules were given starting 2006. Despite the limitations, the study results reveal an effort to dispel the concept of HIF, recognize its manifestations and mainly identify its underlying factors, which can positively or negatively influence fraud. The results of this study may have important implications, as we seek to implement effective interventions that to date have eluded us.


Regarding the definition of HIF that we propose is “an act based on deception or intentional misrepresentation to obtain illegal benefits concerning the coverage provided by health insurance”, which provides us with theoretical support that emphasizes its essential elements. We believe that this will distinguish it from abuse, corruption or error. The multifactorial nature of HIF is evident, as well as the particular characteristics of its manifestations, which are subject to its definition and may differ from one country to another according to its regulatory framework and the scope of health coverage provided. Identifying the factors and their influence will allow any subsequent attempt to propose practices that mitigate HIF.

The factors that have shown strength concerning reducing fraud are auditing, monitoring, sanction and control, nurses’ role (supported by applied studies), the economy, politics and social conditions, the medical record, and the commercial implication (supported by theoretical studies). On the other hand, the factors that have shown strength concerning increasing fraud are sex, age, predominant race, have health insurance, place of residence, medical and surgical treatments, chronic health conditions, risk of illness, deductibles and coinsurance, the complicity between the provider and the insurer, the relationship between the provider and the consumer, the relationship between the consumer and the insurer, the influence of the bosses and the Guanxi, (supported by applied studies), the geography, reimbursement processes and billing characteristics, information asymmetry, and poor economic situation of the patient (supported by theoretical studies).

Based on our results, we recommend that future investigations that explore HIF look for the relationships between the factors and their manifestations. Likewise, we suggest evaluating the relationship between the factors and the fraud theories themselves, developing computational methods that identify factors, identifying the costs generated and their impact on the HS, and proposing and implementing practices that mitigate the positive factors and enhance the negative ones. All with the purpose of help its detection and prevention with a comprehensive approach.

Availability of data and materials

The data supporting analysis of this work and additional files can be found in the main document.



Association for Computing Machinery


Current procedural terminology


Codes for Evaluation and Management


Economics working papers


The Employee Retirement Income Security Act of 1974


Health insurance fraud


Health insurance coverage


Health systems


International Association of Insurance Supervisors


Internal Revenue Service, the federal government of the United States


Medical Subject Headings


National Health Care Anti-Fraud Association


SCImago Journal Rank


A third-party administrator


United States of America


Web of Science


  1. Abdallah, A., Maarof, M. A., & Zainal, A. (2016). Fraud detection system: A survey. Journal of Network and Computer Applications, 68, 90–113.

    Article  Google Scholar 

  2. Akomea-Frimpong, I., Andoh, C., & Dei Ofosu-Hene, E. (2016). Causes, effects and deterrence of insurance fraud: Evidence from Ghana. Journal of Financial Crime, 23(4), 678–699.

    Article  Google Scholar 

  3. Aral, K. D., Güvenir, H. A., Sabuncuoğlu, İ., & Akar, A. R. (2012). A prescription fraud detection model. Computer Methods and Programs in Biomedicine, 106(1), 37–46.

    Article  Google Scholar 

  4. Ardito, L., Messeni Petruzzelli, A., & Albino, V. (2015). From technological inventions to new products: A systematic review and research agenda of the main enabling factors. European Management Review, 12(3), 113–147.

    Article  Google Scholar 

  5. Baltussen, R., Bruce, E., Rhodes, G., Narh-Bana, S. A., & Agyepong, I. (2006). Management of mutual health organizations in Ghana. Tropical Medicine & International Health, 11(5), 654–659.

    Article  Google Scholar 

  6. S. Barrett, ‘Insurance fraud and abuse: A very serious problem’, Ouackuiatch, 2006.

    Google Scholar 

  7. Bauder, R., Khoshgoftaar, T. M., & Seliya, N. (2017). A survey on the state of healthcare upcoding fraud analysis and detection. Health Services and Outcomes Research Methodology, 17(1), 31–55.

    Article  Google Scholar 

  8. Bauder, R. A., & Khoshgoftaar, T. M. (2020). A study on rare fraud predictions with big Medicare claims fraud data. IDA, 24(1), 141–161.

    Article  Google Scholar 

  9. Bayerstadler, A., van Dijk, L., & Winter, F. (2016). Bayesian multinomial latent variable modeling for fraud and abuse detection in health insurance. Insurance: Mathematics and Economics, 71, 244–252.

    Article  Google Scholar 

  10. Borca, G. J. (2001). Technology curtails health care fraud. Managed care (Langhorne, Pa.), 10(4), 50.

    Google Scholar 

  11. Bourgeon, J.-M., & Picard, P. (2014). Fraudulent claims and nitpicky insurers. American Economic Review, 104(9), 2900–2917.

    Article  Google Scholar 

  12. Brooks, G., Button, M., & Gee, J. (2012). The scale of healthcare fraud: A global evaluation. Security Journal, 25(1), 76–87.

    Article  Google Scholar 

  13. Brooks, G., Tunley, M., Button, M., & Gee, J. (2017). Fraud, error and corruption in healthcare: A contribution from criminology.

    Google Scholar 

  14. Brugué, Q., Canal, R., & Paya, P. (2015). “Inteligencia administrativa para abordar” problemas malditos? El caso de las comisiones interdepartamentales’. Gestión y política pública, 24(1), 85–130.

    Google Scholar 

  15. Busch, R. S. (2008). Electronic health records: An audit and internal control guide. John Wiley & Sons.

    Google Scholar 

  16. Busch, R. S. (2012. (Accessed 12 Sept 2020)). Healthcare fraud: Auditing and detection guide, 2nd edition | Wiley. Wiley.

    Book  Google Scholar 

  17. Dionne, G., Giuliano, F., & Picard, P. (2009). Optimal auditing with scoring: Theory and application to insurance fraud. Management Science, 55(1), 58–70.

    Article  Google Scholar 

  18. Dolan, C. M., & Farmer, L. J. (2016). Let the Record Speak . . .: The Power of the Medical Record. The Journal for Nurse Practitioners, 12(2), 88–94.

    Article  Google Scholar 

  19. Dumitru, C. G., Batca, V., & Raileanu, S. (2011). The fraud in the health systems-a Financial of Ethic Problem? Revista de management comparat international/review of international comparative management, 12(6), 319–325.

    Google Scholar 

  20. Duszak, R. S., & Duszak, R. (2011). Adverse action reports against optometrists: Perspectives from the National Practitioner Data Bank over 18 years. Optometry - Journal of the American Optometric Association, 82(5), 318–321.

    Article  Google Scholar 

  21. Ekin, T., Ieva, F., Ruggeri, F., & Soyer, R. (2018). Statistical medical fraud assessment: Exposition to an emerging field: Statistical methods for medical fraud assessment. International Statistical Review, 86(3), 379–402.

    Article  Google Scholar 

  22. Elwyn, G., Edwards, A., Kinnersley, P., & Grol, R. (2000). Shared decision making and the concept of equipoise: the competences of involving patients in healthcare choices. British Journal of General Practice, 50(460), 892–899.

    Google Scholar 

  23. Faux, M., Wardle, J., & Adams, J. (2019). Medicare billing, law and practice: Complex, incomprehensible and beginning to unravel. Journal of Law and Medicine, 27(1), 66–93.

    Google Scholar 

  24. Francis, J. K. (2020). Common patterns of corporate dermatology billing abuses in Medicare data sets. Clinics in Dermatology, 38(3), 284–288.

    Article  Google Scholar 

  25. Gaitonde, R., Oxman, A. D., Okebukola, P. O., & Rada, G. (2016). ‘Interventions to reduce corruption in the health sector. Cochrane Database of Systematic Reviews, 8.

  26. García, P. J. (2019). Corruption in global health: The open secret. The Lancet, 394(10214), 2119–2124.

    Article  Google Scholar 

  27. Gasquoine, P. G., & Jordan, T. L. (2009). Medicare/medicaid billing fraud and abuse by psychologists. Professional Psychology: Research and Practice, 40(3), 279–283.

    Article  Google Scholar 

  28. Geruso, M., & Rosen, H. S. (2015). Insurance fraud in the workplace? Evidence from a dependent verification program. Journal Risk and Insurance, 82(4), 921–946.

    Article  Google Scholar 

  29. Goel, R. K. (2020). Medical professionals and health care fraud: Do they aid or check abuse? Managerial and Decision Economics, 41(4), 520–528.

    Article  Google Scholar 

  30. Green, S. P. (2007). ‘A normative approach to white-collar crime. In International Handbook of White-Collar and Corporate Crime, (pp. 223–247). Springer.

    Chapter  Google Scholar 

  31. Haddad Soleymani, M., Yaseri, M., Farzadfar, F., Mohammadpour, A., Sharifi, F., & Kabir, M. J. (2018). Detecting medical prescriptions suspected of fraud using an unsupervised data mining algorithm. DARU Journal of Pharmaceutical Sciences, 26(2), 209–214.

    Article  Google Scholar 

  32. Hassan, A. K. I., & Abraham, A. (2013). Computational intelligence models for insurance fraud detection: A review of a decade of research. Journal of Network and Innovative Computing, 1(2013), 341–347.

    Google Scholar 

  33. Helmer Jr., J. B. (2012). False claims act: Incentivizing integrity for 150 years for rogues, privateers, parasites and patriots. U. Cin. L. Rev., 81, 1261.

    Google Scholar 

  34. Hennig-Schmidt, H., Selten, R., & Wiesen, D. (2011). ‘How payment systems affect physicians’ provision behaviour—an experimental investigation'. Journal of Health Economics, 30(4), 637–646.

    Article  Google Scholar 

  35. Herland, M., Bauder, R. A., & Khoshgoftaar, T. M. (2019). The effects of class rarity on the evaluation of supervised healthcare fraud detection models. Journal Big Data, 6(1), 21.

    Article  Google Scholar 

  36. Herland, M., Bauder, R. A., & Khoshgoftaar, T. M. (2020). Approaches for identifying U.S. medicare fraud in provider claims data. Health Care Management Science, 23(1), 2–19.

    Article  Google Scholar 

  37. Herland, M., Khoshgoftaar, T. M., & Bauder, R. A. (2018). Big Data fraud detection using multiple medicare data sources. Journal Big Data, 5(1), 29.

    Article  Google Scholar 

  38. Hillerman, T., Souza, J. C. F., Reis, A. C. B., & Carvalho, R. N. (2017). Applying clustering and AHP methods for evaluating suspect healthcare claims. Journal of Computational Science, 19, 97–111.

    Article  Google Scholar 

  39. Huber, W. (2017). ‘Forensic accounting, fraud theory, and the end of the fraud triangle. Journal of Theoretical Accounting Research, 12(2).

  40. Hyman, D. A. (2001). Health care fraud and abuse: Market change, social norms, and the trust “reposed in the workmen”’. The ‘Journal of Legal Studies, 30(S2), 531–567.

    Article  Google Scholar 

  41. IAIS, ‘Principios Básicos de Seguros, Estándares, Guías y Metodología de Evaluación’, 2011.

    Google Scholar 

  42. Jator, E. K., & Hughley, K. (2014). ABO/Rh testing, antibody screening, and biometric technology as tools to combat insurance fraud: An example and discussion. Laboratoriums Medizin, 45(1), e3–e7.

    Article  Google Scholar 

  43. Johnson, M. E., & Nagarur, N. (2016). Multi-stage methodology to detect health insurance claim fraud. Health Care Management Science, 19(3), 249–260.

    Article  Google Scholar 

  44. Jones, B., & Jing, A. (2011). Prevention not cure in tackling healthcare fraud. Bulletin of the World Health Organization, 89(12), 858–859.

    Article  Google Scholar 

  45. Jou, S., & Hebenton, B. (2007). Insurance fraud in Taiwan: Reflections on regulatory effort and criminological complexity. International Journal of the Sociology of Law, 35(3), 127–142.

    Article  Google Scholar 

  46. Joudaki, H., et al. (2015). ‘Improving Fraud and Abuse Detection in General Physician Claims: A Data Mining Study. International Journal of Health Policy and Management, 5(3), 165–172.

    Article  Google Scholar 

  47. Kacem, M., Melki, S., Nouira, S., Khelil, M., Belguith, A. S., & Abdelaziz, A. B. (2019). For a honest maghreb care system. Systematic review of the international literature on corruption in the health care system. La Tunisie Medicale, 97(3), 397–406 Available:

    Google Scholar 

  48. Kang, H., Hong, J., Lee, K., & Kim, S. (Apr. 2010). The effects of the fraud and abuse enforcement program under the National Health Insurance program in Korea. Health Policy, 95(1), 41–49.

    Article  Google Scholar 

  49. Kelley, B. P., Shauver, M. J., & Chung, K. C. (2015). Management of acute postoperative pain in hand surgery: A systematic review. The Journal of Hand Surgery, 40(8), 1610–1619.

    Article  Google Scholar 

  50. Kerschbamer, R., & Sutter, M. (2017). The economics of credence goods – A survey of recent lab and field experiments*. CESifo Economic Studies, 63(1), 1–23.

    Article  Google Scholar 

  51. Konijn, R. M., Duivesteijn, W., Meeng, M., & Knobbe, A. (2015). Cost-based quality measures in subgroup discovery. Journal of Intelligent Information System, 45(3), 337–355.

    Article  Google Scholar 

  52. Kose, I., Gokturk, M., & Kilic, K. (Nov. 2015). An interactive machine-learning-based electronic fraud and abuse detection system in healthcare insurance. Applied Soft Computing, 36, 283–299.

    Article  Google Scholar 

  53. Krause, J. H. (2013). Kickbacks, self-referrals, and false claims. Chest, 144(3), 1045–1050.

    Article  Google Scholar 

  54. Kruk, M. E., Gage, A. D., Arsenault, C., Jordan, K., Leslie, H. H., Roder-DeWan, S., … Pate, M. (2018). High-quality health systems in the sustainable development goals era: Time for a revolution. The Lancet Global Health, 6(11), e1196–e1252.

    Article  Google Scholar 

  55. Kumar, R., Rangarajan, K., & Ranganathan, N. (2011). Health Insurance in India—A Study of Provider’s perceptions in Delhi & the NCR. Journal of Health Management, 13(3), 259–277.

    Article  Google Scholar 

  56. Lammers, F., & Schiller, J. (2010). Einflussfaktoren für betrügerisches Verhalten von Versicherungsnehmern: erste experimentelle Befunde. ZVersWiss, 99(5), 649–663.

    Article  Google Scholar 

  57. Lee, J., Shin, H., & Cho, S. (Jul. 2020). A medical treatment based scoring model to detect abusive institutions. Journal of Biomedical Informatics, 107, 103423.

    Article  Google Scholar 

  58. Lee, S. J., Abbey, J. D., Heim, G. R., & Abbey, D. C. (2016). Seeing the forest for the trees: Institutional environment impacts on reimbursement processes and healthcare operations. Journal of Operations Management, 47–48(1), 71–79.

    Article  Google Scholar 

  59. Lesch, W. C., & Baker, B. R. (2013). Balancing the insurance equation: Understanding the climate for managing consumer insurance fraud and abuses. Journal of Insurance Issues, 82–120.

  60. Levi, M., & Burrows, J. (2008). Measuring the impact of fraud in the UKA conceptual and empirical journey. British Journal of Criminology, 48(3), 293–318.

    Article  Google Scholar 

  61. Li, J., Huang, K.-Y., Jin, J., & Shi, J. (Sep. 2008). A survey on statistical methods for health care fraud detection. Health Care Manage Sci, 11(3), 275–287.

    Article  Google Scholar 

  62. Lin, C., Lin, C.-M., & Hong, C. (2009). The development of dentist practice profiles and management. Journal of Evaluation in Clinical Practice, 15(1), 4–13.

    Article  Google Scholar 

  63. Lin, C., Lin, C.-M., Li, S.-T., & Kuo, S.-C. (2008). Intelligent physician segmentation and management based on KDD approach. Expert Systems with Applications, 34(3), 1963–1973.

    Article  Google Scholar 

  64. Lin, K. C., Yeh, C. L., & Huang, S. Y. (2013). Use of Data Mining Techniques to Detect Medical Fraud in Health Insurance. Applied Mechanics and Materials, 284, 1574–1578.

    Article  Google Scholar 

  65. Liou, F.-M., Tang, Y.-C., & Chen, J.-Y. (2008). Detecting hospital fraud and claim abuse through diabetic outpatient services. Health Care Manage Sci, 11(4), 353–358.

    Article  Google Scholar 

  66. Liu, Q., & Vasarhelyi, M. (2013). Healthcare fraud detection: A survey and a clustering model incorporating geo-location information.

    Google Scholar 

  67. Manchikanti, L., & Hirsch, J. A. (Apr. 2009). Obama health care for all Americans: Practical implications. Pain Physician, 12(2), 289–304.

    Article  Google Scholar 

  68. Manocchia, M., Scott, A., & Wang, M. C. (2012). Health consumer susceptibility to medical care fraud: an exploratory analysis. IJPP, 8(1/2/3), 136.

    Article  Google Scholar 

  69. Maroun, W., & Solomon, J. (2014). Whistle-blowing by external auditors: Seeking legitimacy for the south African audit profession? Accounting Forum, 38(2), 111–121.

    Article  Google Scholar 

  70. Massi, M. C., Ieva, F., & Lettieri, E. (2020). Data mining application to healthcare fraud detection: a two-step unsupervised clustering method for outlier detection with administrative databases. BMC Medical Informatics and Decision Making, 20(1), 160.

    Article  Google Scholar 

  71. Mundy, D., & Chadwick, D. W. (2002). A system for secure electronic prescription handling.

    Google Scholar 

  72. Munn, Z., Peters, M. D. J., Stern, C., Tufanaru, C., McArthur, A., & Aromataris, E. (2018). Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Medical Research Methodology, 18(1), 143.

    Article  Google Scholar 

  73. Musal, R. M. (2010). Two models to investigate Medicare fraud within unsupervised databases. Expert Systems with Applications, 37(12), 8628–8633.

    Article  Google Scholar 

  74. Myckowiak, V. (2009). Compliance in interventional pain practices. Pain Physician, 12(3), 671–677.

    Article  Google Scholar 

  75. NHCAA, ‘The Problem of Health Care Fraud: A serious and costly reality for all Americans’, National Health Care Anti-Fraud Association (NHCAA), 2018. Accessed 5 Sept 2020. Available:

    Google Scholar 

  76. Ogunbanjo, G. A., & van Bogaert, D. K. (2014). Ethics in health care: Healthcare fraud. South African Family Practice, 56(1), S10–S13.

    Article  Google Scholar 

  77. Olsen, J., & Baisch, M. J. (Feb. 2014). An integrative review of information systems and terminologies used in local health departments. Journal of the American Medical Informatics Association, 21(e1), e20–e27.

    Article  Google Scholar 

  78. Onwubiko, C. (2020). Fraud matrix: A morphological and analysis-based classification and taxonomy of fraud. Computers & Security, 96, 101900.

    Article  Google Scholar 

  79. Ormerod, T. C., Ball, L. J., & Morley, N. J. (Apr. 2012). Informing the development of a fraud prevention toolset through a situated analysis of fraud investigation expertise. Behaviour & Information Technology, 31(4), 371–381.

    Article  Google Scholar 

  80. Palutturi, S., Makkurade, S. R., Ahri, R. A., & Putri, A. S. E. (2019). Potential for fraud of health service claims to BPJS health at Tenriawaru public hospital, bone regency, Indonesia. International Journal of Innovation, Creativity and Change, 8(5), 70–90.

    Google Scholar 

  81. Park, J., Kim, M., & Yoon, S. (2016). Evaluation of large-scale data to detect irregularity in payment for medical services: An extended use of Benford’s law. Methods of Information in Medicine, 55(03), 284–291.

    Article  Google Scholar 

  82. Perez, V., & Wing, C. (2019). Should We Do More to Police Medicaid Fraud? Evidence on the Intended and Unintended Consequences of Expanded Enforcement. American Journal of Health Economics, 5(4), 481–508 Available:

    Article  Google Scholar 

  83. Pfaff, K., Baxter, P., Jack, S., & Ploeg, J. (Jan. 2014). An integrative review of the factors influencing new graduate nurse engagement in interprofessional collaboration. Journal of Advanced Nursing, 70(1), 4–20.

    Article  Google Scholar 

  84. Phillipsen, N. C., Setlow, P. D., & Jacob, I. S. (Nov. 2008). The Most costly billing practices ever. The Journal for Nurse Practitioners, 4(10), 761–765.

    Article  Google Scholar 

  85. Pickett, K. S., & Pickett, J. M. (2002). Financial crime investigation and control. John Wiley & Sons.

    Google Scholar 

  86. Plomp, M. G. A., & Grijpink, J. (2011). Combating identity fraud in the public domain: information strategies for healthcare and criminal justice. In Proceedings of the 11th European Conference on e-Government, (pp. 451–458).

    Google Scholar 

  87. Rabecs, R. N. (2005). Health care fraud under the new Medicare part D prescription drug program. J. Crim. L. & Criminology, 96, 727.

    Google Scholar 

  88. Ramamoorti, S., & Olsen, W. (2007). Fraud: The human factor. Financial Executive, 23(6).

  89. Rashidian, A., Joudaki, H., & Vian, T. (2012). No evidence of the effect of the interventions to combat health care fraud and abuse: a systematic review of literature. PloS one, 7(8), e41988.

    Article  Google Scholar 

  90. Ribeiro, R., Silva, B., Pimenta, C., & Poeschl, G. (2020). Why do consumers perpetrate fraudulent behaviors in insurance? Crime Law Social Change, 73(3), 249–273.

    Article  Google Scholar 

  91. Sheffali, S., & Deepa, D. V. (2019). Effective Fraud Detection in Healthcare Domain using Popular Classification Modeling Techniques. IJITEE, 8(11), 579–583.

    Article  Google Scholar 

  92. Shi, Y., Sun, C., Li, Q., Cui, L., Yu, H., & Miao, C. (2016). A fraud resilient medical insurance claim System. In Proceedings of the thirtieth AAAI conference on artificial intelligence, (pp. 4393–4394). Arizona: Phoenix.

    Google Scholar 

  93. Shin, H., Park, H., Lee, J., & Jhee, W. C. (2012). A scoring model to detect abusive billing patterns in health insurance claims. Expert Systems with Applications, 39(8), 7441–7450.

    Article  Google Scholar 

  94. Smith, S., Cell, P., Anderson, L., & Larson, T. (May 2013). Minnesota Department of Human Services audit of medication therapy management programs. Journal of the American Pharmacists Association, 53(3), 248–253.

    Article  Google Scholar 

  95. Sparrow, M. K. (2008). Fraud in the US healthcare system: Exposing the vulnerabilities of automated payments systems. Social Research: An International Quarterly, 75(4), 1151–1180.

    Google Scholar 

  96. Steinmeier, M. (2016). Fraud in sustainability departments? An exploratory study. Journal of Business Ethics, 138(3), 477–492.

    Article  Google Scholar 

  97. Sun, H., et al. (2020). Medical Knowledge Graph to Enhance Fraud, Waste, and Abuse Detection on Claim Data: Model Development and Performance Evaluation. JMIR Medical Informatics, 8(7), e17653.

    Article  Google Scholar 

  98. Thornton, D., Brinkhuis, M., Amrit, C., & Aly, R. (2015). Categorizing and describing the types of fraud in healthcare. Procedia Computer Science, 64, 713–720.

    Article  Google Scholar 

  99. Timofeyev, Y., & Busalaeva, T. (2019). Current trends in insurance fraud in Russia: Evidence from a survey of industry experts. Security Journal.

  100. Tovino, S. A. (2006). Final HIPAA Enforcement Rule Clarifies Process for Imposition of Civil Money Penalties. 2.

  101. Transparency International, ‘Definition fraud’, 2017. (Accessed 12 Sept 2020).

    Google Scholar 

  102. Travaille, P., Müller, R. M., Thornton, D., & Van Hillegersberg, J. (2011). Electronic Fraud Detection in the US Medicaid Healthcare Program: Lessons Learned from other Industries.

    Google Scholar 

  103. Tricco, A. C., Lillie, E., Zarin, W., O’Brien, K. K., Colquhoun, H., Levac, D., … Straus, S. E. (2018). PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation. Annals of Internal Medicine, 169(7), 467–473.

    Article  Google Scholar 

  104. Tseng, L.-M. (2016). The link between guanxi and customer–salesperson collusion: The case of Taiwan’s insurance industry. International Journal of Conflict Management, 27(3), 353–378.

    Article  Google Scholar 

  105. Tseng, L.-M., & Kang, Y.-M. (2015). ‘Managerial authority, turnover intention and medical insurance claims adjusters’ Recommendations for Claim Payments’. The Geneva Papers on Risk and Insurance-Issues and Practice, 40(2), 334–352.

    Article  Google Scholar 

  106. USAO-EDLA, ‘Louisiana Couple and Their Business Plead Guilty To Operating Sham Medical Reimbursement Account Program That Defrauded the IRS and Program Participants Out Of Over $48 Million’, 2019. (Accessed 20 Sept 2020).

    Google Scholar 

  107. Vahdati, S., & Yasini, N. (2015). Factors affecting internet frauds in private sector: A case study in cyberspace surveillance and scam monitoring agency of Iran. Computers in Human Behavior, 51, 180–187.

    Article  Google Scholar 

  108. Vian, T. (2020). Anti-corruption, transparency and accountability in health: concepts, frameworks, and approaches. Global Health Action, 13(sup1), 1694744.

    Article  Google Scholar 

  109. Vian, T., Brinkerhoff, D. W., Feeley, F. G., Salomon, M., & Vien, N. T. K. (2012). Confronting corruption in the health sector in Vietnam: Patterns and prospects: Health sector corruption in Vietnam. Public Administration and Development, 32(1), 49–63.

    Article  Google Scholar 

  110. Victorri-Vigneau, C., Larour, K., Simon, D., Pivette, J., & Jolliet, P. (2009). Création et validation d’un outil de détection de la fraude par falsification d’ordonnance à partir des bases de données de l’Assurance Maladie. Therapies, 64(1), 27–31.

    Article  Google Scholar 

  111. W. H. Organization (2016). Universal health coverage: Moving towards better health: Action framework for the Western Pacific region. Manila: WHO Regional Office for the Western Pacific.

    Google Scholar 

  112. T. T. H. Wan and C. A. Shasky, ‘Mining medical claims data with exploratory to confirmatory statistical methods’, IJPP, vol. 8, no. 1/2/3, p. 122, 2012, doi:

  113. Wang, D. (2014). Health care, American style: How did we arrive? Where will we go? Psychiatric Annals, 44(7), 342–348.

    Article  Google Scholar 

  114. Wang, S.-L., Pai, H.-T., Wu, M.-F., Wu, F., & Li, C.-L. (2017). The evaluation of trustworthiness to identify health insurance fraud in dentistry. Artificial Intelligence in Medicine, 75, 40–50.

    Article  Google Scholar 

  115. Weiss, S. M., Kulikowski, C. A., Galen, R. S., Olsen, P. A., & Natarajan, R. (2015). Managing healthcare costs by peer-group modeling. Applied Intelligence, 43(4), 752–759.

    Article  Google Scholar 

  116. World Bank (2018). Combating corruption. World Bank (Accessed 12 Sept 2020).

    Google Scholar 

  117. World Bank, ‘Financiamiento de alto rendimiento para alcanzar la cobertura universal de la salud: Impulsar un crecimiento sostenible e inclusivo en el siglo XXI’, World Bank, 2019. (Accessed 12 Sept 2020).

    Google Scholar 

  118. Yang, W.-S. (2003). ‘A Process Pattern Mining Framework for the Detection of Health Care Fraud and Abuse’, Ph.D. thesis, National Sun Yat-Sen University, Taiwan.

    Google Scholar 

  119. Yusuf, T. O. (2010). Brokers and the control of postcontractual opportunism in the Nigerian insurance market. Journal of Financial Crime.

  120. Yusuf, T. O., & Ajemunigbohun, S. S. (2015). ‘Effectiveness, Efficiency, And Promptness Of Claims Handling Process In The Nigerian Insurance Industry. European Journal of Business and Economics, 10(2).

  121. Zhou, J., Wang, S., Zhou, J., & Xu, Y. (2016). Measurement of the Severity of Opportunistic Fraud in Personal Injury Insurance:Evidence from China’. Emerging Markets Finance and Trade.

  122. Zourrig, H., Park, J., El Hedhli, K., & Zhang, M. (2018). The effect of cultural tightness–looseness on fraud perception in insurance services. Int Journal Quality & Service Sciences, 10(2), 138–148.

    Article  Google Scholar 

Download references


Not applicable.


Dirección de Investigación de la Universidad Peruana de Ciencias Aplicadas - B-013-2021.

Author information




JVO conceptualised the study and designed the scoping review, planned the search strategies, carried out the screening, extraction of the studies, examined and evaluated the quality of the articles, the data analysis, wrote the first draft of the review article, wrote the manuscript, approved the final version of the manuscript and accepts responsibility for the entire content of the article. LBB performed the formal analysis, assessed the quality of the articles and the writing of the first original draft, accepted the final version and accepted responsibility for the entire content of the article. DM conceptualised the study and designed the scoping review, planned the search strategies, performed the screening, extraction of the studies, examined and assessed the quality of the articles, analysed the data, wrote the first draft of the review article, revised the manuscript, approved the final version of the manuscript and accepts responsibility for the entire content of the article. The author(s) read and approved the final manuscript.

Corresponding authors

Correspondence to José Villegas-Ortega or David Mauricio.

Ethics declarations

Ethics approval and consent of participants

Does not apply.

Consent for publication

Does not apply.

Competing interests

JVO and LBB currently work in a government entity, the National Superintendency of Health in Peru.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1.

Scoping Reviews (PRISMA-ScR) Checklist. This file contains details of the Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) Checklist.

Additional file 2.

Complete search strategy and characteristics of the included studies. This file contains details of the complete search strategy in the seven sources of information consulted.

Additional file 3.

Excel matrix. This file contains details of all processed studies.

Additional file 4.

Quality scoring of included studies. This file contains details of the four quality assessment factors for each of the 67 studies included in the analysis.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Villegas-Ortega, J., Bellido-Boza, L. & Mauricio, D. Fourteen years of manifestations and factors of health insurance fraud, 2006–2020: a scoping review. Health Justice 9, 26 (2021).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI:


  • Healthcare
  • Fraud
  • Insurance
  • Behaviour
  • Factor
  • Manifestation